Mira Pharmaceuticals Stock (NASDAQ: MIRA)

Dernières nouvelles pour Mira Pharmaceuticals (NASDAQ:MIRA) Stock

Mira Pharmaceuticals

Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

MIRA Pharmaceuticals, Inc. - Common Stock

Mira Pharmaceuticals Inc

MIRAI Corp

MIRAIT One Corp

MIRAMAR RESOURCES LTD by MIRAMAR RESOURCES LTD

MIRATI THERAPEUTICS INC COM

MIRACLE ENTMT INC by Miracle Entertainment Inc.

Miracle Entertainment Inc

MIRAGE ENERGY CORP by Mirage Energy Corporation

Mirage Energy Corp

MIRAMAR HOTE & INVST CO by Miramar Hotel & Investment Co., Ltd.

Miramar Hotel & Investment Co Ltd

TAKARA LEBEN CO LTD by Takara Leben Co., Ltd.

Mirarth Holdings Inc

MIRASOL RESOURCES LTD by Mirasol Resources Ltd.

Mirasol Resources Ltd

Miratap Inc

MIRAVANT MEDICAL TECHS by Miravant Medical Technologies

Miravant Medical Technologies

With U.S. stock futures trading lower this morning on Friday, some of the stocks that may grab investor focus today are as follows:
<ul>
<li>Wall Street expects Carnival Corporation &amp; Plc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCL#NYSE">CCL</a>) to report quarterly earnings at 8 cents per share on revenue of $5.93 billion before the opening bell, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. Carnival shares gained 0.4% to $25.27 in after-hours trading.</li>
<li>NIKE, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) reported better-than-expected second-quarter financial results after the closing bell on Thursday. Nike reported second-quarter revenue of $12.35 billion, beating analyst estimates of $12.13 billion. The company reported second-quarter earnings of 78 cents per share, beating analyst estimates of 65 cents per share. Nike shares slipped 0.5% to $76.68 in the after-hours trading session.</li>
<li>Analysts expect Winnebago Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WGO#NYSE">WGO</a>) to post quarterly earnings at 20 cents per share on revenue of $672.23 million before the opening bell. Winnebago shares gained 2% to $52.99 in the after-hours trading session.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<ul>
<li>FedEx Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDX#NYSE">FDX</a>) posted stronger-than-expected results for its second quarter. The company also announced that it has decided to pursue a full separation of FedEx Freight through the capital markets, creating a new publicly traded company. FedEx shares climbed 8.7% to $300.00 in the after-hours trading session.</li>
<li>BlackBerry Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BB#NYSE">BB</a>) reported third-quarter adjusted earnings of two cents per share, beating analyst estimates of a loss of one cent per share, according to Benzinga Pro. The company posted quarterly revenue of $162 million. BlackBerry expects fourth-quarter revenue of $126 million to $135 million versus estimates of $161.49 million. BlackBerry shares rose 2% to $3.04 in after-hours trading.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42582254/top-3-consumer-stocks-you-may-want-to-dump-this-quarter">Top 3 Consumer Stocks You May Want To Dump This Quarter</a></li>
</ul>
Photo courtesy: Shutterstock

Earnings

News

Pre-Market Outlook

Markets

Trading Ideas

FedEx, Nike And 3 Stocks To Watch Heading Into Friday

Board of FUJI SOFT Unanimously Supports KKR Second Tender Offer and Recommends Tender

Reported Earlier, KKR Reaffirms Commitment To FUJI SOFT With Tender Offer Extension, Board Labels Bain's Bid Hostile

Cathie Wood, the founder of Ark Investment Management LLC, predicts a surge in mergers and acquisitions after President-elect Donald Trump defeats Vice President Kamala Harris in the 2024 election.
What Happened: &#8220;M&amp;A has been prevented by the FTC. That is going to change,&#8221; Wood, popularly known for leading ARK Innovation ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKK#NYSE">ARKK</a>) <a href="https://www.youtube.com/watch?v=zd-ZoXq5R3w">said</a> in an interview with Bloomberg Television on Thursday.
The seasoned investor continues to maintain her optimistic view on cryptocurrencies, projecting that Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) may hit $1.5 million by 2030. Wood highlighted how Bitcoin is becoming &#8220;more scarce than gold,&#8221; pointing out that after the April halving, its annual supply increase has decreased to 0.9%. 
According to Wood, production rises in tandem with the price of gold. Bitcoin prevents that from occurring.
Her remarks come as Bitcoin has gained 120% this year and is now trading above $100,000. Wood highlights Bitcoin&#8217;s fixed supply cap of 21 million coins and credits the surge to increased institutional interest and regulatory certainty.
See Also: <a href="https://www.benzinga.com/news/24/12/42608814/elon-musks-doge-role-in-government-set-for-fascinating-tough-fight-says-analyst-walter-isaacson-sees-challenges-for-tesla-ceos-federal-path">Elon Musk&#8217;s DOGE Role In Government Set For &#8216;Fascinating Tough Fight,&#8217; Says Analyst — Walter Isaacson Sees Challenges For Tesla CEO&#8217;s Federal Path</a>
The emergence of Bitcoin ETFs has significantly increased retail investor interest, with prominent offerings such as iShares Bitcoin Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBIT#NASDAQ">IBIT</a>), Grayscale Bitcoin Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GBTC#NYSE">GBTC</a>), Fidelity Wise Origin Bitcoin Fund (BATS:<a class="ticker" href="https://www.benzinga.com/stock/FBTC#BATS">FBTC</a>), ARK 21Shares Bitcoin ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKB#BATS">ARKB</a>), Bitwise Bitcoin ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BITB#NYSE">BITB</a>), Grayscale Bitcoin Mini Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTC#NYSE">BTC</a>), ProShares Bitcoin ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BITO#NYSE">BITO</a>), and Volatility Shares Trust 2x Bitcoin Strategy ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/BITX#BATS">BITX</a>), providing various options for investors seeking exposure to the cryptocurrency market.
Why It Matters: The Ark Innovation ETF manager, known for her <a href="https://www.benzinga.com/24/12/42608224/cathie-woods-thursday-moves-dumps-buzzing-stocks-tesla-and-palantir">high-conviction bets on disruptive technology</a>, has recently adjusted her fund&#8217;s positions. ARKK sold 14,016 shares of Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) at $436.17 and 33,402 shares of Palantir Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>) at $74.21 on Thursday.
Wood also expressed optimism about broader market participation under Trump&#8217;s presidency. &#8220;The market&#8217;s going to broaden out right now and reward companies who are at the leading edge of innovation,&#8221; she said during a previous CNN appearance, though <a href="https://www.benzinga.com/markets/equities/24/12/42262916/ark-invests-cathie-wood-says-stock-market-will-broaden-out-under-trump-but-growth-wont-be-linear-nothing-goes-up-in-a-straight-line">cautioning that growth wouldn&#8217;t be linear</a>.
Her outlook aligns with Bank of America analysts&#8217; predictions of increased M&amp;A activity, particularly in banking and biotech sectors, under a Republican administration. Analysts note that financial sector deals historically <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41979935/golden-years-for-ma-deals-ahead-under-trump-analysts-highlight-top-10-large-cap-candidates">increased by 50% during Republican presidencies</a>.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/12/42608297/tom-lee-explains-why-fewer-cuts-in-2025-could-boost-the-market-urges-investors-to-buy-the-dip-amid-recent-volatility">Tom Lee Explains Why &#8216;Fewer Cuts In 2025&#8217; Could Boost The Market, Urges Investors To &#8216;Buy The Dip&#8217; Amid Recent Volatility</a></li>
</ul>
Image via Ark Invest

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

ARK 21Shares Bitcoin ETF ARK 21Shares Bitcoin ETF

ARKB

ARKK

Bitwise Bitcoin ETF Common Shares of Beneficial Interest

BITB

BITO

BITX

Fidelity Wise Origin Bitcoin Fund Fidelity Wise Origin Bitcoin Fund

FBTC

GBTC

IBIT

PLTR

TSLA

Cathie Wood Says Bitcoin Is 'More Scarce Than Gold' — Predicts M&A Surge Under Trump 2.0

In 2020, CORXEL (formerly Ji Xing) acquired the rights to develop and commercialize aficamten in Greater China (including the Chinese mainland, Hong Kong SAR and Macau SAR, and Taiwan) from Cytokinetics in accordance with Cytokinetics' global registration programs. Aficamten received Breakthrough Therapy Designation for the treatment of symptomatic obstructive hypertrophic cardiomyopathy (oHCM) from The Center for Drug Evaluation of the China National Medical Products Administration which recently accepted the New Drug Application for aficamten tablets for&nbsp;the treatment of oHCM for Priority Review.
Sanofi will now acquire CORXEL's rights relating to aficamten in Greater China for an undisclosed amount. Cytokinetics&nbsp;remains eligible to receive up to $150 million in development and commercial milestone payments from Sanofi as well as royalties in the low-to-high teens on future sales of aficamten in Greater China. Cytokinetics is now also eligible to receive additional undisclosed payments in connection with the execution of the agreement between Sanofi and CORXEL.

CYTK

Cytokinetics Announces Sanofi's Acquisition Of Aficamten Rights For HCM Treatment In Greater China

Macro Economic Events

Econ #s

Economics

Reported Earlier, People's Bank of China Loan Prime Rate Unchanged At 3.10%

Reported Earlier, China Loan Prime Rate 5Y For December Unchanged At 3.60%

BBJP

WisdomTree Trust Japan Total Dividend Fund

Reported Earlier, Japan National Consumer Price Index (MoM) For November 0.6% Vs. 0.4% Prior

Reported Earlier, Japan National Core Consumer Price Index (YoY) For November 2.7% Vs. 2.6% Est.; 2.3% Prior

Marques Brownlee, popularly known as MKBHD, highlights how Google&#8217;s Veo 2 AI video generator, owned by Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>), outshines OpenAI&#8217;s Sora model.
What Happened: On Thursday, Brownlee shared a YouTube Short of his observations pointing out that while Sora often displayed its AI nature through inaccuracies in movement and physics, Veo 2 delivered more realistic results.
However, he acknowledged that Veo 2 still has flaws, such as issues with complex scenes and garbled text.
One of the standout points in Brownlee's comparison was his emphasis on YouTube data—something that sets Veo 2 apart from other models, including OpenAI's Sora.
See Also: <a href="https://www.benzinga.com/24/12/42545936/samsung-galaxy-s25-ultra-and-s25-leaks-show-off-sleek-curved-design-and-slimmer-bezels-than-apples-iphone-16-pro-max?itm_source=parsely-api">Samsung Galaxy S25 Ultra And S25+ Leaks Feature Sleek Curved Design And Slimmer Bezels Than Apple&#8217;s iPhone 16 Pro Max</a>
He suggested that the difference between the two is like "using a little bit of YouTube data" versus "owning YouTube and just using all of it."
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="SORA vs VEO 2 - AI Generated Videos" width="500" height="281" src="https://www.youtube.com/embed/74J0uiZk29k?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
In March this year, former OpenAI CTO Mira Murati&#8217;s <a href="https://www.benzinga.com/news/24/03/37704187/is-openais-viral-ai-video-generator-sora-trained-on-youtube-and-instagram-cto-mira-murati-is-not-sur">uncertainty about whether</a> YouTube videos were used to train Sora created controversy. The following month, YouTube CEO Neal Mohan said that using YouTube videos in such manner would violate their policy.
When asked if Google is using YouTube to train Gemini, Mohan said, &#8220;Google uses YouTube content really in accordance. Again, back with those terms of service or individual contracts that we might have with creators or uploaders to our platform.&#8221;
Subscribe to the <a href="https://bztechtrends.beehiiv.com/subscribe">Benzinga Tech Trends newsletter</a> to get all the latest tech developments delivered to your inbox.
Why It Matters: Earlier this week, Elon Musk, who co-founded OpenAI in 2015 and left the AI startup in 2018 over some differences, <a href="https://www.benzinga.com/tech/24/12/42525899/elon-musk-reacts-after-sundar-pichai-shares-veo-2-as-google-looks-to-challenge-openais-sora-in-ai-video-race-looks-impressive">expressed admiration</a> for Google&#8217;s Veo 2.
On the flip side, Marc Andreessen has praised OpenAI&#8217;s Sora model, suggesting it may have <a href="https://www.benzinga.com/tech/24/12/42501018/marc-andreessen-praises-openais-sora-video-model-we-may-have-basically-just-solved-the-fundamental-challenge-of-robotics">solved a significant challenge</a> in robotics.
Earlier this year, Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) also introduced its <a href="https://www.benzinga.com/top-stories/24/09/40945913/as-the-ai-arms-race-wages-on-amazon-takes-shot-at-rival-adobe-with-new-text-to-video-product">AI-powered video tool</a> for advertisers, joining Adobe&#8217;s Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADBE#NASDAQ">ADBE</a>) Firefly Video Model <a href="https://www.benzinga.com/tech/24/12/42525899/elon-musk-reacts-after-sundar-pichai-shares-veo-2-as-google-looks-to-challenge-openais-sora-in-ai-video-race-looks-impressive">in the competitive market</a>.
In October 2024, Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) unveiled Movie Gen, a new tool that generates videos, images, and audio <a href="https://www.benzinga.com/24/12/42608267/meta-flexes-movie-gen-ai-as-instagram-boss-teases-video-editing-magic-for-2025">based on text prompts</a>.
Photo via Wikimedia courtesy of Ramsey Cardy/Collision via Sportsfile
Check out more of Benzinga&#8217;s Consumer Tech coverage by <a href="https://www.benzinga.com/topic/consumer-tech">following this link</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/12/42546621/elon-musk-agrees-as-satya-nadella-reflects-on-ais-global-impact-in-2024-from-cancer-research-to-rainforest-conservation-and-more?itm_source=parsely-api">Elon Musk Agrees With Satya Nadella As Microsoft CEO Reflects On &#8216;Incredible Speed&#8217; Of AI Diffusion In 2024</a></li>
</ul>
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.

Tech

ADBE

AMZN

GOOG

GOOGL

Marques Brownlee Breaks Down How Google's AI Video Generator Veo2 Outpaces OpenAI's Sora

El Salvador made full use of the market drop Thursday by buying as many as 11 Bitcoins (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>), worth over a million dollars, for its reserve.
What happened: According to the National Bitcoin Office, an agency tasked by President Nayib Bukele to oversee all things related to the leading cryptocurrency, the Central American nation upped its daily purchase tally to 11, 10 more than the one Bitcoin per day policy.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">&#x1f1f8;&#x1f1fb;We just transferred over a million dollars worth of Bitcoin to our Strategic Bitcoin Reserve. <a href="https://t.co/4ZrxGw9Od0">pic.twitter.com/4ZrxGw9Od0</a>
&mdash; The Bitcoin Office (@bitcoinofficesv) <a href="https://twitter.com/bitcoinofficesv/status/1869899405391999015?ref_src=twsrc%5Etfw">December 20, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
With the latest grab, the country's Bitcoin <a href="https://bitcoin.gob.sv/">stockpile </a>grew to 5,980.77, worth $581 million at current prices, with an unrealized profit of over $307 million.
The aggressive dip-buying followed <a href="https://www.benzinga.com/trading-ideas/movers/24/12/42608314/bitcoin-ethereum-dogecoin-retreat-further-as-crypto-liquidations-top-1-billion-analyst-lays-out-scenario-for-btc-losing-96k-support">a sharp downturn in the market</a>, which saw the apex cryptocurrency fall below $96,000.
See Also:<a href="https://www.benzinga.com/24/12/42519107/if-you-invested-1000-in-bitcoin-when-the-first-bitcoin-etf-was-filed-heres-how-much-youd-have-today"> </a><a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42560698/microstrategys-aggressive-bitcoin-strategy-raises-eyebrows-in-crypto-community">MicroStrategy&#8217;s Aggressive Bitcoin Strategy Raises Eyebrows In Crypto Community</a>
Why It Matters: The purchases come a day after El Salvador signed a $1.4 billion loan arrangement with the International Monetary Fund, which included a condition that the country scale back its Bitcoin push.
However, Stacy Herbert, Director of the National Bitcoin Office, stated that El Salvador will continue to buy Bitcoin at an "accelerated pace" and that Bitcoin-friendly policies will continue to be implemented.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">&#x1f1f8;&#x1f1fb;EL SALVADOR SECURES $3.5 FUNDING DEAL &#x27a1;&#xFE0F;Bitcoin remains legal tender &#x27a1;&#xFE0F;El Salvador will continue buying bitcoin (at possibly an accelerated pace) for its Strategic Bitcoin Reserve &#x27a1;&#xFE0F;Bitcoin capital markets will continue to be built; for example, the recent tokenized issuance…
&mdash; Stacy Herbert &#x1f1f8;&#x1f1fb;&#x1f680; (@stacyherbert) <a href="https://twitter.com/stacyherbert/status/1869752262186217868?ref_src=twsrc%5Etfw">December 19, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
El Salvador became the first country to adopt the leading digital asset as its legal tender in 2021. Despite these efforts, <a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41608795/remember-the-passports-for-bitcoin-initiative-in-el-salvador-its-not-going-so-well">Bitcoin adoption</a> among Salvadorans remains low, with the majority still relying on the U.S. dollar as the country&#8217;s primary currency.
Price Action: At the time of writing, Bitcoin was exchanging hands at $97,618.09, down 3.33% in the last 24 hours, according to <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA..">data from Benzinga Pro</a>.&nbsp;
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42545656/bitcoin-is-no-manhattan-real-estate-peter-schiff-challenges-microstrategys-micheal-saylor-btc-doesnt-generate-any-income">Bitcoin Is No Manhattan Real Estate, Peter Schiff Challenges MicroStrategy&#8217;s Michael Saylor: &#8216;BTC Doesn&#8217;t Generate Any Income&#8217;</a></li>
</ul>

El Salvador Buys Bitcoin Dip, Scoops $1 Million Worth Of BTC A Day After IMF Urges Scaling Back

President-elect Donald Trump has transferred his entire stake in Trump Media &amp; Technology Group Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DJT#NASDAQ">DJT</a>) to his revocable trust, according to Securities and Exchange Commission filings released on Thursday.
What Happened: The transfer of 114,750,000 shares, representing approximately 53% ownership of the company, was completed Tuesday with Trump listed as the sole beneficiary. The shares were gifted to the Donald J. Trump Revocable Trust without monetary compensation, the filing shows.
The move comes just days after Trump <a href="https://www.benzinga.com/general/social-media/24/12/42454492/djt-stock-in-focus-as-trump-set-to-ring-nyse-bell-today-heres-why-president-elect-once-threatened-to-shift-trump-media-from-nasdaq">rang the opening bell at the New York Stock Exchange</a>, where DJT stock has surged over 100% year-to-date. The company&#8217;s shares closed at $35.41 on Tuesday, valuing Trump&#8217;s transferred stake at approximately $4 billion.
The transfer follows Trump&#8217;s September pledge not to sell his shares in the Truth Social parent company. During that time, he had publicly criticized Nasdaq over routine trading halts, threatening to move the listing to the NYSE.
See Also: <a href="https://www.benzinga.com/markets/equities/24/12/42608297/tom-lee-explains-why-fewer-cuts-in-2025-could-boost-the-market-urges-investors-to-buy-the-dip-amid-recent-volatility">Tom Lee Explains Why &#8216;Fewer Cuts In 2025&#8217; Could Boost The Market, Urges Investors To &#8216;Buy The Dip&#8217; Amid Recent Volatility</a>
Why It Matters: DJT stock has shown significant volatility this year, trading between $11.75 and $79.38. The company has drawn increased attention as Trump prepares to return to the presidency while facing multiple legal challenges, including discussions around presidential <a href="https://www.benzinga.com/news/legal/24/12/42405278/trump-plays-presidential-immunity-card-in-truth-social-lawsuit-battle">immunity related to Trump Media</a>.
The filing notes that while the shares are now held by the trust, Trump maintains indirect ownership as the trust&#8217;s beneficiary. 
The move represents one of Trump&#8217;s largest financial maneuvers ahead of his <a href="https://www.benzinga.com/news/21/01/19072354/trump-acknowledges-a-new-administration-takes-over-on-jan-20-calls-for-calm-to-be-restored">scheduled Jan. 20 inauguration</a> for a second non-consecutive term as president.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/12/42608814/elon-musks-doge-role-in-government-set-for-fascinating-tough-fight-says-analyst-walter-isaacson-sees-challenges-for-tesla-ceos-federal-path">Elon Musk&#8217;s DOGE Role In Government Set For &#8216;Fascinating Tough Fight,&#8217; Says Analyst — Walter Isaacson Sees Challenges For Tesla CEO&#8217;s Federal Path</a></li>
</ul>
Image via Flickr
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Equities

Trump Transfers Entire DJT Stake To Revocable Trust Ahead Of Inauguration

Management

Donald Trump Jr. Transferred 114.75M Shares Of Trump Media & Technology Group To Revocable Trust, Including 553,176 Shares Held In Escrow Until March 2025; No Shares Were Sold During Transfer

Donald J. Trump Gifted 114.75M Shares Of Trump Media & Technology Group To Trump Revocable Trust; No Shares Were Sold During Transfer

Samsung Electronics Co. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SSNLF#OTC">SSNLF</a>) Galaxy S22 users face severe issues following the One UI 6.1.1 update.
What Happened: Released in September 2024, the update has caused devices to become permanently bricked, with some users also experiencing random reboots and overheating problems.
Affected users have been advised by Samsung&#8217;s customer support to replace the phone&#8217;s motherboard, which is costly as the devices are out of warranty.
The issue seems to primarily affect Exynos 2200-powered Galaxy S22 units in Europe and parts of Asia.
See Also: <a href="https://www.benzinga.com/tech/24/12/42525551/ahead-of-trumps-return-to-white-house-us-approves-406m-grant-for-taiwans-chipmaker-globalwafers?itm_source=parsely-api">Ahead Of Trump&#8217;s Return To White House, US Approves $406M Grant For Taiwan&#8217;s Chipmaker GlobalWafers</a>
&#8220;I've tried everything Samsung suggested: clearing the cache, factory resets—you name it. Nothing worked,&#8221; one user complained on Samsung's official online forum.
Adding, &#8220;I even had a Samsung repair tech come to my house. They suggested my motherboard needs to be replaced but refused to fix it under warranty because of a small, superficial crack on my screen (which can barely even be picked up by a camera).&#8221;
Samsung did not immediately respond to <a href="https://pro.benzinga.com/dashboard">Benzinga's</a> request for comments.
Subscribe to the <a href="https://bztechtrends.beehiiv.com/subscribe">Benzinga Tech Trends newsletter</a> to get all the latest tech developments delivered to your inbox.
Why It Matters: The South Korean smartphone maker reported a <a href="https://www.benzinga.com/markets/asia/24/10/41645191/samsung-profits-soar-but-companys-nvidia-ai-chip-race-lag-allows-sk-hynix-micron-to-take-the-lead-in">net income of 9.78 trillion won</a> ($7.1 billion) for the quarter ending in September.
Earlier this year, Samsung also announced plans to <a href="https://www.benzinga.com/news/24/09/40812318/samsung-to-reportedly-slash-global-workforce-by-up-to-30-in-certain-divisions-amid-intense-competiti">reduce its global workforce</a> by up to 30% in certain divisions, amid fierce competition from Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) and Huawei Technologies.
According to Statista, Samsung Electronics&#8217; Mobile Experience (MX) division brought in approximately $21.6 billion as of the third quarter of 2024, making it the top revenue driver.
The tech giant is currently preparing for the launch of its Galaxy S25 series, featuring a <a href="https://www.benzinga.com/24/12/42545936/samsung-galaxy-s25-ultra-and-s25-leaks-show-off-sleek-curved-design-and-slimmer-bezels-than-apples-iphone-16-pro-max">sleek design and running</a> on One UI 7.
Image Courtesy &#8211; Samsung
Check out more of Benzinga's Consumer Tech coverage by <a href="https://www.benzinga.com/topic/consumer-tech">following this link</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/global/24/12/42499566/google-willow-nvidias-china-troubles-trump-on-ai-and-more-this-week-in-artificial-intelligence?itm_source=parsely-api">Google Willow, Nvidia's China Troubles, Trump On AI, And More: This Week In Artificial Intelligence</a></li>
</ul>
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.

AAPL

SSNLF

Samsung One UI 6.1.1 Update Is Turning This Galaxy Series Phones Into Paperweights: Bricking, Random Reboots And Overheating Reported

Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>) entered into a partnership with the decentralized oracle network Chainlink (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/link/usd">LINK</a>) Thursday in a bid to expand its ecosystem.
What Happened: The partnership would see the integration of Chainlink&#8217;s&nbsp;standard for blockchain interoperability as&nbsp;the primary cross-chain infrastructure for Shibarium, Shiba Inu&#8217;s Layer-2 blockchain. 
Additionally, the Cross-Chain Token standard would make Shiba Inu ecosystem tokens like SHIB, Doge Killer (LEASH), and Bone ShibaSwap (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">BONE</a>) available across 12 different blockchains.
Shiba Inu&#8217;s mysterious lead, Shytoshi Kusama, deemed the development &#8220;huge news&#8221; for the ecosystem. 
&#8220;Expect much more from this partnershib,&#8221; Kusama said, in typical Shiba Inu lingo.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">This is HUGE news for the <a href="https://twitter.com/hashtag/SHIBARMY?src=hash&amp;ref_src=twsrc%5Etfw">#SHIBARMY</a> and <a href="https://twitter.com/search?q=%24SHIB&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$SHIB</a>, <a href="https://twitter.com/search?q=%24BONE&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BONE</a>, AND <a href="https://twitter.com/search?q=%24LEASH&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$LEASH</a>. Expect much more from this partnershib! <a href="https://t.co/99nRkzdA01">https://t.co/99nRkzdA01</a>
&mdash; Shytoshi Kusama&#x2122; (@ShytoshiKusama) <a href="https://twitter.com/ShytoshiKusama/status/1869832150545297508?ref_src=twsrc%5Etfw">December 19, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
For the curious, Chainlink acts as a bridge between the blockchain and the outside world, enabling smart contracts to access data and events from off-chain sources. Based on Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>), the platform&#8217;s flagship Cross-Chain Interoperability Protocol allows developers to build applications that can send tokens and messages across the blockchain.
See Also:&nbsp;<a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42604209/from-bitcoin-to-multi-coin-the-formula-for-choosing-a-winning-digital-asset-index-for-inve">From Bitcoin to Multi-Coin: The Formula for Choosing a Winning Digital Asset Index for Investors</a>
Why It Matters: The inclusion of Chainlink&#8217;s standard could increase the accessibility of Shiba Inu assets, potentially leading to increased demand. The integration could also unlock more industry-specific use cases for Shibarium, a growing Layer-2 solution.
Earlier this week, Shiba Inu announced the airdrop of its newly launched meme coin&nbsp;Shifu&nbsp;(SHIFU) for its loyal community members. A significant proportion of the supply has been set aside for holders of SHIB, BONE, and LEASH. 
Price Action: The associated tokens failed to respond positively. SHIB was down 8.36% in the last 24 hours, while LINK was down 6.40%, according to <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA..">data from Benzinga Pro</a>.&nbsp;
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/24/12/42602503/dave-portnoy-says-he-owns-15-million-bitcoin-13-million-xrp-bet-it-and-set-it-not-trading">Dave Portnoy Says He Owns $1.5 Million Bitcoin, $1.3 Million XRP: &#8216;Bet It And Set It, Not Trading&#8217;</a></li>
</ul>

$BONE

$ETH

$LINK

$SHIB

Shytoshi Kusama Shares 'Huge News' As Shiba Inu Partners With Chainlink To Boost Shibarium, Ecosystem Tokens

New Street Research analyst Pierre Ferragu has expressed support for Tesla Inc. CEO Elon Musk&#8216;s upcoming role in the newly announced Department of Government Efficiency while acknowledging the challenges ahead in reforming federal operations.
What Happened: &#8220;Will be fascinating to see DOGE at work: Elon&#8217;s method in a government environment,&#8221; Ferragu wrote on X on Thursday, noting the potential resistance from &#8220;lawmakers &amp; civil servants defending their personal interest.&#8221;
The Tesla CEO&#8217;s approach to government reform has drawn attention from notable figures including Walter Isaacson, an American journalist known for his acclaimed biographies of influential figures including Henry Kissinger, Benjamin Franklin, Albert Einstein, Steve Jobs, Jennifer Doudna, and most recently, Musk himself. 
Isaacson recently appeared on CNBC&#8217;s &#8216;Squawk Box&#8217; to discuss Musk&#8217;s new challenge in leading the DOGE and his relationship with Trump.
Isaacson stated that Musk&#8217;s handling of DOGE will be distinct from his previous approach with Twitter, now X, where he reduced the workforce by 80% to increase efficiency. Unlike his private ventures, DOGE will be a federal agency, meaning Musk won't be directly paying employees. 
Isaacson also pointed out that Musk holds significant influence in the defense sector and noted that Trump&#8217;s support will play a key role in shaping Congress&#8217;s response.
The comments follow President-elect Donald Trump&#8216;s November announcement appointing Musk and former presidential candidate Vivek Ramaswamy to lead DOGE, a new initiative aimed at restructuring federal agencies and reducing the government&#8217;s $6.5 trillion annual spending. The department is scheduled to <a href="https://www.benzinga.com/news/global/24/11/41927289/trump-appoints-elon-musk-and-vivek-ramaswamy-to-lead-doge-targeting-bureaucracy-and-65-trillion-federal-spending-we-will-not-go-gently">complete its work by Jul. 4, 2026</a>.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Will be fascinating to see DOGE at work: Elon's method in a government environment, with much more random individual agency (lawmakers &amp; civil servants giving the middle finger defending their personal interest) I'd root for DOGE and see them successful. It is going to be a… <a href="https://t.co/IroQKvB9Mh">https://t.co/IroQKvB9Mh</a>
&mdash; Pierre Ferragu (@p_ferragu) <a href="https://twitter.com/p_ferragu/status/1869833273469481214?ref_src=twsrc%5Etfw">December 19, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/markets/equities/24/12/42608297/tom-lee-explains-why-fewer-cuts-in-2025-could-boost-the-market-urges-investors-to-buy-the-dip-amid-recent-volatility">Tom Lee Explains Why &#8216;Fewer Cuts In 2025&#8217; Could Boost The Market, Urges Investors To &#8216;Buy The Dip&#8217; Amid Recent Volatility</a>
Why It Matters: Musk, who has been vocal about reducing government expenditures, called the initiative one that would &#8220;send shockwaves through the system.&#8221; 
His appointment comes as he continues to challenge <a href="https://www.benzinga.com/markets/equities/24/11/42206297/amid-elon-musks-push-for-drones-and-ai-for-combat-transformation-analyst-pierre-ferragu-says-shift-the-defense-budget-in-favor-of-startups">traditional government spending approaches</a>, recently criticizing military programs like Lockheed Martin Corp.&#8216;s F-35 program, estimated to cost $1.8 trillion.
Financial experts have weighed in on the potential impact. InCred Global Wealth U.K. analyst Mario Georgiou suggests the initiative could yield annual savings between $50-100 billion, though this represents a small portion of the <a href="https://www.benzinga.com/24/11/42131911/donald-trump-appointed-doge-to-have-marginal-impact-saving-50-100-billion-says-analyst-as-elon-musk-aims-to-target-500-billion-plus-in-federal-expenditures">projected $6.7 trillion federal budget</a>.
The department&#8217;s mandate includes restructuring federal agencies, reducing regulations, and implementing accountability measures. While expressing optimism about DOGE&#8217;s potential success, Ferragu noted it would be &#8220;a fascinating tough fight,&#8221; highlighting the complexity of bringing private sector efficiency to government operations.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42608267/meta-flexes-movie-gen-ai-as-instagram-boss-teases-video-editing-magic-for-2025">Instagram Boss Shows How You Can Turn Yourself Into A Puppet — And That&#8217;s Just The Beginning</a></li>
</ul>
Image Via Shutterstock 
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Government

Elon Musk's DOGE Role In Government Set For 'Fascinating Tough Fight,' Says Analyst — Walter Isaacson Sees Challenges For Tesla CEO's Federal Path

Social media platform, Bluesky is set to create its own payment system, a process that could take at least 12 months. The company is also planning to introduce subscriptions early next year.
What Happened: In an interview with Buffer on Thursday, COO Rose Wang said that Bluesky aims to align its financial incentives with those of its users, creators, and developers.
She said, &#8220;As they're making more money, we should be making money, but if they're not making money, we shouldn't be making money.&#8221;
Wang explained that the goal is to facilitate payments within the app and across other platforms, increasing transaction volumes. Creators will retain most of the earnings, while Bluesky will take a percentage of the transaction fees.
See Also: <a href="https://www.benzinga.com/24/12/42568430/senate-minority-leader-mcconnell-urges-supreme-court-to-reject-tiktoks-delay-request-pushing-for-january-ban-amid-first-amendment-debate?itm_source=parsely-api">Mitch McConnell Urges Supreme Court To Reject TikTok&#8217;s Delay Request, Says Platform Hoping For Less Hostile DOJ In Trump Administration</a>
&#8220;Coming is like 12 months. Payment systems take a while, but absolutely it&#8217;s things that we are prioritizing,&#8221; she stated.
Wang also spoke about the upcoming subscription model will offer users improved self-expression tools, such as custom icons and domains. However, core app features will remain accessible without a paywall.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="Bluesky&#039;s Rose Wang on Subscriptions, Creator Monetization, and More" width="500" height="281" src="https://www.youtube.com/embed/GxgTgEgwAiY?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
Why It Matters: Several other social media platforms have also developed integrated payment systems to support transactions and enable monetization. For example:&nbsp;
Meta Platforms, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) has Meta Pay, which powers transactions across Instagram, Messenger, and Facebook.
YouTube, owned by Alphabet Inc.'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) Google, provides monetization options like Super Chats, Channel Memberships, and tipping during live streams.
Elon Musk's X, formerly Twitter, is working on <a href="https://www.benzinga.com/markets/cryptocurrency/24/06/39382770/inside-elon-musks-plan-to-add-payments-to-x">expanding its payment capabilities</a> as part of its push to become a super app.
Bluesky, founded by Jack Dorsey, has been gaining traction, <a href="https://www.benzinga.com/general/social-media/24/12/42421291/alexandria-ocasio-cortez-aoc-hits-1-million-followers-with-top-bluesky-account-mark-cuban-gains-popularity-jack-dorsey-notably-absent">reaching nearly 25 million users</a> by Dec. 10, 2024. Notable figures like Alexandria Ocasio-Cortez and Mark Cuban have contributed to its popularity.
Image via Bluesky
Check out more of Benzinga&#8217;s Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/technicals/24/12/42509206/soundhound-ai-soars-over-700-short-squeeze-potential-has-traders-talking?itm_source=parsely-api">SoundHound AI Soars 700%: Short Squeeze Potential Has Traders Talking</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Social Media

Bluesky Planning Payment Platform That Could Arrive In 12 Months, Says COO Rose Wang, Aims To Align Financial Incentives With Users

Australian computer scientist Craig Wright, who has consistently claimed to be Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) creator Satoshi Nakamoto, was held in contempt of court on Thursday and handed out a one-year suspended prison sentence for continuing to sue developers.
What Happened: The case was brought by the Crypto Open Patent Alliance, a non-profit that has waged a legal battle against Wright&#8217;s claims of being the inventor of the world&#8217;s largest cryptocurrency, according to a <a href="https://www.theguardian.com/technology/2024/dec/19/craig-wright-man-who-falsely-claimed-to-be-bitcoin-creator-sentenced-for-continuing-to-sue-developers">report </a>by The Guardian.
Earlier in May, Judge James Mellor ruled that Wright had lied &#8220;extensively and repeatedly&#8221;&nbsp;and forged documents to support&nbsp;his false claim and asked him to publicly deny being Satoshi and his copyright ownership of the Bitcoin whitepaper.
The Crypto Open Patent Alliance stated that Wright ignored this injunction and sued developers by bringing cases against cryptocurrency developers totaling more than £900 billion ($1.12 trillion) in October.
See Also:&nbsp;<a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42601193/senator-lummis-introduces-strategic-bitcoin-reserve-proposal">Senator Lummis Introduces Strategic Bitcoin Reserve Proposal</a>
Judge James Mellor ruled on Thursday that Wright was in contempt of court, sentencing him to 12 months in jail suspended for two years.
Why It Matters: Wright has been a <a href="https://www.benzinga.com/markets/cryptocurrency/22/12/30182902/craig-wright-drops-controversial-quest-to-prove-hes-bitcoin-creator-only-validation-i-seek">contentious figure in the Bitcoin community</a> since he posted a blog in 2016 claiming, with questionable evidence, to be the apex cryptocurrency&#8217;s inventor.
Since then, he has gone to court in defense of his claim,&nbsp;filing lawsuits that allege&nbsp;libel for calling him a fraud or copyright infringement. In February,&nbsp;<a href="https://www.benzinga.com/markets/cryptocurrency/24/02/36949178/is-craig-wright-actually-satoshi-nakamoto-bitcoins-alleged-creators-assertion-deemed-a-bra" target="_blank" rel="noreferrer noopener">Wright's assertion was deemed a ‘brazen lie'</a>&nbsp;in a U.K. High Court, and he was <a href="https://www.benzinga.com/markets/cryptocurrency/24/07/39808275/craig-wright-adds-disclaimer-to-website-admitting-hes-not-bitcoin-founder-satoshi-nakamoto">directed</a> to issue a legal disclaimer on his website homepage, X feed, and all Slack channels&nbsp;that he isn&#8217;t Satoshi. 
The real identity of Satoshi Nakamoto remains a subject of controversy and intrigue, with a <a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41242615/peter-todd-is-satoshi-nakamoto-bitcoin-core-developer-denies-hbo-documentary-claims-im-not">recent HBO documentar</a>y identifying Bitcoin core engineer Peter Todd as the pseudonymous founder.
Photo Courtesy: Dan Henson On Shutterstock.com
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/24/12/42602503/dave-portnoy-says-he-owns-15-million-bitcoin-13-million-xrp-bet-it-and-set-it-not-trading">Dave Portnoy Says He Owns $1.5 Million Bitcoin, $1.3 Million XRP: &#8216;Bet It And Set It, Not Trading&#8217;</a></li>
</ul>

Self-Proclaimed Bitcoin Inventor Craig Wright Awarded Prison Sentence For Defying Court Order

China kept its benchmark lending rates unchanged on Friday, with the one-year loan prime rate held at 3.1% and the five-year LPR at 3.6%. 
The People's Bank of China's decision comes as it works to stimulate economic growth and support the weakening yuan. The one-year LPR affects corporate and household loans, while the five-year LPR is used for mortgage rates. 
This move follows a <a href="https://www.benzinga.com/economics/macro-economic-events/24/12/42570219/whartons-jeremy-siegel-calls-stock-sell-off-a-healthy-reality-check-market-was-overly-optimistic">25-basis-point rate cut</a> by the U.S. Federal Reserve on Wednesday. The Fed also indicated that it will implement only two interest rate cuts in 2025, fewer than the four previously projected in September.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/12/42608297/tom-lee-explains-why-fewer-cuts-in-2025-could-boost-the-market-urges-investors-to-buy-the-dip-amid-recent-volatility">Tom Lee Explains Why &#8216;Fewer Cuts In 2025&#8217; Could Boost The Market, Urges Investors To &#8216;Buy The Dip&#8217; Amid Recent Volatility</a></li>
</ul>
Image Via Shutterstock 
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Asia

China Keeps Benchmark Lending Rates Steady As Fed Signals Fewer Cuts Ahead

Major U.S. indices closed Thursday with mixed results. The Dow Jones Industrial Average edged up by 0.04%, while the S&amp;P 500 slipped 0.09%, and the tech-focused NASDAQ dropped 0.1%.
These are the top stocks that gained the attention of retail traders and investors throughout the day.
Nike Inc.
Nike&#8217;s stock edged up by 0.26%, closing at $77.10. The stock reached an intraday high of $77.94 and a low of $76.43, with a 52-week range between $123.39 and $70.75. Nike reported its <a href="https://www.benzinga.com/general/sports/24/12/42605414/nike-q2-earnings-revenue-beat-eps-beat-shares-jump-nike-being-nike-again">second-quarter earnings</a>, revealing revenue of $12.35 billion, surpassing analyst expectations of $12.13 billion. Earnings per share were 78 cents, beating the 65 cents forecast by analysts. Despite a year-over-year revenue decline, the company showed resilience.
FedEx Corp.
FedEx shares rose by 1.00%, closing at $275.88. The stock&#8217;s intraday high was $278.48, with a low of $273.19, and it has traded between $313.84 and $234.45 over the past year. FedEx announced <a href="https://www.benzinga.com/news/earnings/24/12/42605034/fedex-stock-rallies-on-better-than-expected-q2-eps-freight-spin-off-announcement">better-than-expected second-quarter earnings</a> of $4.05 per share, beating the $3.91 consensus. However, revenue fell short at $22 billion, impacted by weaker FedEx Freight performance.
BlackBerry Ltd.
BlackBerry&#8217;s stock fell by 1.00%, closing at $2.98. It reached an intraday high of $3.08 and a low of $2.96, with a 52-week range of $4.27 to $2.01. The company reported third-quarter earnings, with revenue at $162 million and <a href="https://www.benzinga.com/news/earnings/24/12/42606549/blackberry-beats-q3-earnings-estimates-but-soft-guidance-keeps-shares-in-check">adjusted earnings of two cents per share</a>, exceeding expectations. Despite beating estimates, soft guidance kept the stock in check.
Rigetti Computing Inc.
Rigetti&#8217;s stock plummeted by 30.12%, closing at $7.47. The stock hit an intraday high of $10.18 and a low of $6.75, with a 52-week range from $12.75 to $0.66. The stock has seen <a href="https://www.benzinga.com/general/market-summary/24/12/42569883/quantum-computing-rigetti-d-wave-skyrocket-up-to-300-in-5-sessions-after-google-unveils-willow-chip-but-analysts-urge-caution-not-every-tiktok-guitarist-is-the-next-taylor-swift">significant volatility</a>, with a 52.95% surge on Thursday. Analysts have urged caution despite the recent gains following Google&#8217;s unveiling of its Willow quantum chip.
Tesla Inc.
Tesla&#8217;s stock declined by 0.90%, closing at $436.17. The stock&#8217;s intraday high was $456.36, with a low of $420.02, and it has ranged between $488.54 and $138.80 over the past year. Tesla&#8217;s European registrations <a href="https://www.benzinga.com/24/12/42571913/tesla-registrations-drop-by-nearly-41-in-november-in-eu-dragging-down-optimism-for-over-500000-ev-deliveries-in-q4">dropped by 41% in November</a>, raising concerns about its ability to meet its global EV delivery targets.
Prepare for the day&#8217;s trading&nbsp;<a href="https://editorial.benzinga.com/wp-admin/Premarket%20Movers%20&amp;%20News">with top premarket movers and news</a>&nbsp;by Benzinga.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/tech/24/12/42525257/analyst-hikes-teslas-price-target-to-515-musk-expresses-hope-for-stock-to-touch-69042?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Elon Musk Hopes TSLA Stock Will Reach $690 As Analysts Raise Price Target Despite Technical Indicators Flashing Warning Signals</a></li>
</ul>
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noreferrer noopener">Shivdeep Dhaliwal</a>

RGTI

Nike, Fedex, Blackberry, Rigetti, And Tesla: Why These 5 Stocks Are On Investors' Radars Today

MIRA stock rallies 154% on preclinical results for ketamine drug

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
MIRA Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/mira-stock-quote/">MIRA</a>) stock is seeing massive gains on Monday after the pre-clinical-stage pharmaceutical company released data from its pre-clinical study of Ketamir-2.



Ketamir-2. is MIRA Pharmaceuticals&rsquo; novel oral ketamine analog. It&rsquo;s being studied as a potential <a href="https://finance.yahoo.com/news/mira-pharmaceuticals-reveals-preclinical-success-120000778.html">treatment for neurological and neuropsychiatric disorders</a>. That includes depression, treatment-resistant depression and post-traumatic stress disorder (PTSD).



Here&rsquo;s what MIRA Pharmaceuticals chairman and CEO Erez Aminov said about the new data.




&ldquo;Our vision at MIRA is to transform the treatment landscape for neurological and neuropsychiatric disorders. Ketamir-2 shows great promise in addressing these debilitating conditions with improved efficacy and safety, offering new hope and better quality of life for patients and their families. Importantly, we are seeing a drumbeat of promising data this year that we hope will allow us to file an IND and begin to test our theories about Ketamir-2 in actual patients in the near term.&rdquo;




<h2>What This Means for MIRA Stock</h2>



MIRA stock could benefit greatly if the company is able to move forward with its IND plans. The company&rsquo;s shares are already gaining today with more than 116 million shares traded. For the record, its daily average trading volume is about 654,000 shares.



MIRA Stock is up 318.1% as of Monday afternoon.



Investors will want to stick around for more of the most recent stock market stories!



We have all of the hottest stock market news investors need to know about on Monday! Among that is what has shares of Nio&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/nio-stock-quote/">NIO</a>), Reddit&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/rddt-stock-quote/">RDDT</a>) and Cassava Sciences&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/sava-stock-quote/">SAVA</a>) stock moving today. All of that info is good to go at the links below!



<h2>More Monday Stock Market News</h2>



<ul><li><a href="https://investorplace.com/2024/07/nio-stock-alert-more-details-emerge-about-upcoming-nio-day-2024/">NIO Stock Alert: More Details Emerge About Upcoming Nio Day 2024</a></li>



<li><a href="https://investorplace.com/2024/07/rddt-stock-alert-reddit-nabs-new-deals-with-nfl-nba/">RDDT Stock Alert: Reddit Nabs New Deals with NFL, NBA</a></li>



<li><a href="https://investorplace.com/2024/07/sava-stock-alert-cassava-sciences-pops-on-late-stage-trial-update/">SAVA Stock Alert: Cassava Sciences Pops on Late-Stage Trial Update</a></li>
</ul>On Penny Stocks and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>



On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/07/why-is-mira-pharmaceuticals-mira-stock-up-318-today/">Why Is MIRA Pharmaceuticals (MIRA) Stock Up 318% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is MIRA Pharmaceuticals (MIRA) Stock Up 318% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are a hot topic that traders are going to want to know about and we have all of the latest news on Tuesday morning!



Moving stocks this morning are earnings reports, a settlement agreement, the pricing of a public offering and more.



Let&rsquo;s get into that below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Warrantee (NASDAQ:<a href="https://investorplace.com/stock-quotes/wrnt-stock-quote/">WRNT</a>) stock is rocketing close to 254% alongside heavy pre-market trading.</li>



<li>Nature&rsquo;s Miracle (NASDAQ:<a href="https://investorplace.com/stock-quotes/nmhi-stock-quote/">NMHI</a>) shares are soaring more than 122% with strong early morning trading.</li>



<li>Volato (NYSEMKT:<a href="https://investorplace.com/stock-quotes/soar-stock-quote/">SOAR</a>) stock is surging nearly 78% with heavy early morning trading today.</li>



<li>Frequency Electronics (NASDAQ:<a href="https://investorplace.com/stock-quotes/feim-stock-quote/">FEIM</a>) shares are rising almost 33% alongside its <a href="https://www.marketwatch.com/story/frequency-electronics-shares-climb-on-higher-4q-earnings-a32189da">Q4 earnings report</a>.</li>



<li>Mammoth Energy Services (NASDAQ:<a href="https://investorplace.com/stock-quotes/tusk-stock-quote/">TUSK</a>) stock is heading over 29% higher after <a href="https://www.nasdaq.com/press-release/cobra-acquisitions-llc-announces-settlement-agreement-prepa-2024-07-22">announcing a settlement agreement</a>.</li>



<li>ENGlobal (NASDAQ:<a href="https://investorplace.com/stock-quotes/eng-stock-quote/">ENG</a>) shares are gaining more than 22% without any clear news.</li>



<li>Wheeler Real Estate IT (NASDAQ:<a href="https://investorplace.com/stock-quotes/whlr-stock-quote/">WHLR</a>) stock is jumping over 20% with no news to report.</li>



<li>Greenlane (NASDAQ:<a href="https://investorplace.com/stock-quotes/gnln-stock-quote/">GNLN</a>) shares are climbing more than 19% despite a lack of news on Tuesday.</li>



<li>SCYNEXIS (NASDAQ:<a href="https://investorplace.com/stock-quotes/scyx-stock-quote/">SCYX</a>) stock is getting an over 15% boost on a <a href="https://www.nasdaq.com/press-release/scynexis-receive-10-million-milestone-payment-gsk-triggered-delivery-completed-furi">$10 million milestone payment</a>.</li>



<li>Professional Diversity (NASDAQ:<a href="https://investorplace.com/stock-quotes/ipdn-stock-quote/">IPDN</a>) shares are up more than 13% on Tuesday morning.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>TransCode Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/rnaz-stock-quote/">RNAZ</a>) stock is crashing more than 59% after <a href="https://www.nasdaq.com/press-release/transcode-therapeutics-inc-announces-pricing-public-offering-2024-07-22">pricing a public offering</a>.</li>



<li>Mira Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/mira-stock-quote/">MIRA</a>) shares are plummeting close to 31% <a href="https://investorplace.com/2024/07/why-is-mira-pharmaceuticals-mira-stock-up-318-today/">after a massive rally yesterday</a>.</li>



<li>Brera (NASDAQ:<a href="https://investorplace.com/stock-quotes/brea-stock-quote/">BREA</a>) stock is diving nearly 25% with strong pre-market trading this morning.</li>



<li>CareMax (NASDAQ:<a href="https://investorplace.com/stock-quotes/cmax-stock-quote/">CMAX</a>) shares are tumbling over 22% <a href="https://www.benzinga.com/news/24/07/39892411/caremax-shares-are-up-by-more-than-200-what-you-need-to-know">after a rally yesterday</a>.</li>



<li>Nukkleus (NASDAQ:<a href="https://investorplace.com/stock-quotes/nukk-stock-quote/">NUKK</a>) stock is taking a more than 19% beating after a recent rally.</li>



<li>Castellum (NYSEMKT:<a href="https://investorplace.com/stock-quotes/ctm-stock-quote/">CTM</a>) shares are sliding over 19% <a href="https://investorplace.com/2024/07/why-is-castellum-ctm-stock-moving-today/">alongside volatility yesterday</a>.</li>



<li>Exicure (NASDAQ:<a href="https://investorplace.com/stock-quotes/xcur-stock-quote/">XCUR</a>) stock is falling almost 16% as shares <a href="https://investorplace.com/2024/07/why-is-exicure-xcur-stock-down-27-today/">continue to come off a recent rally</a>.</li>



<li>Quoin Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/qnrx-stock-quote/">QNRX</a>) shares are dropping more than 15% today.</li>



<li>Polaris (NYSE:<a href="https://investorplace.com/stock-quotes/pii-stock-quote/">PII</a>) stock is slipping over 15% after <a href="https://www.marketwatch.com/story/polaris-stock-tumbles-11-after-earnings-fall-far-short-of-consensus-and-company-cuts-full-year-outlook-c3299335">missing earnings estimates</a>.</li>



<li>Netcapital (NASDAQ:<a href="https://investorplace.com/stock-quotes/ncpl-stock-quote/">NCPL</a>) shares close out our pre-market stock movers down more than 14%.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/07/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-tuesday-july-23rd/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Mira Pharmaceuticals&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/mira-stock-quote/">MIRA</a>) stock is down on Tuesday as the clinical-stage pharmaceutical company&rsquo;s shares come off of a major rally on Monday.



Shares of MIRA stock closed out Monday&rsquo;s normal trading hours up 627.4%. That came alongside heavy trading with <a href="https://finance.yahoo.com/quote/MIRA/">more than 153 million shares traded</a>. For comparison, its daily average trading volume is about 3.2 million shares.



Mira Pharmaceuticals stock experienced this rally after releasing data from a <a href="https://investorplace.com/2024/07/why-is-mira-pharmaceuticals-mira-stock-up-318-today/">pre-clinical study of Ketamir-2</a>. This is the company&rsquo;s novel oral ketamine analog designed to treat neurological and neuropsychiatric disorders.



The big news here is that the results were positive. This has the company excited about the prospect of furthering the development of Ketamir-2 and submitting an investigational new drug (IND) application for it.



<h2>MIRA Stock Movement on Tuesday</h2>



Considering the massive rally MIRA shares underwent yesterday, it makes sense they would give up some of those gains in the days to follow. This has the stock dropping 27.4% as of Tuesday morning.



Today&rsquo;s dip comes with more than 5.5 million shares changing hands this morning. That&rsquo;s already above its daily average trading volume but is well below yesterday&rsquo;s heavy trading.



Investors who are seeking out even more of the most recent stock market stories today will want to keep reading!



We have all of the hottest stock market news that traders need to know about on Tuesday! That includes everything happening with shares of TransCode Therapeutics&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/rnaz-stock-quote/">RNAZ</a>) stock, Nature&rsquo;s Miracle&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/nmhi-stock-quote/">NMHI</a>)&nbsp;stock and Warrantee&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/wrnt-stock-quote/">WRNT</a>) stock today. All of this info is ready to go at the links below!



<h2>More Stock Market News for Tuesday</h2>



<ul><li><a href="https://investorplace.com/2024/07/why-is-transcode-therapeutics-rnaz-stock-down-62-today/">Why Is TransCode Therapeutics (RNAZ) Stock Down 62% Today?</a></li>



<li><a href="https://investorplace.com/2024/07/trade-of-the-day-buy-sentinelone-s-stock-amid-cybersecurity-carnage/">Trade of the Day: Buy SentinelOne (S) Stock Amid Cybersecurity Carnage</a></li>



<li><a href="https://investorplace.com/2024/07/why-is-natures-miracle-nmhi-stock-up-94-today/">Why Is Nature&rsquo;s Miracle (NMHI) Stock Up 94% Today?</a></li>
</ul>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/07/why-is-mira-pharmaceuticals-mira-stock-down-27-today/">Why Is Mira Pharmaceuticals (MIRA) Stock Down 27% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Mira Pharmaceuticals (MIRA) Stock Down 27% Today?

Earnings Week Ahead: Walmart, Home Depot, Alibaba, Cisco and more

MIRA Mira Pharmaceuticals files $100M mixed securities shelf

MIRA Pharmaceuticals files $100M mixed securities shelf

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Mira Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/mira-stock-quote/">MIRA</a>) just reported results for the second quarter of 2024.<ul><li>Mira Pharmaceuticals reported earnings per share of -11 cents. This was below the analyst estimate for EPS of -10 cents.</li><li>The company did not report any revenue for the quarter.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/mira-stock-earnings-mira-pharmaceuticals-for-q2-of-2024/">MIRA Stock Earnings: Mira Pharmaceuticals Misses EPS for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

MIRA Stock Earnings: Mira Pharmaceuticals Misses EPS for Q2 2024

MIRA Pharmaceuticals, Inc. ( ($MIRA) ) has shared an update. MIRA Pharmaceuticals, Inc. announces a significant leadership change as Michael Jerman...

MIRA Pharmaceuticals Appoints New Board Member and Chairman

MIRA Pharmaceuticals (MIRA), has submitted an Investigational New Drug application to the U.S. Food and Drug Administration for Ketamir-2, its nove...

MIRA Pharmaceuticals submits IND to FDA for Ketamir-2

AMAT

ASTS

ASXC

ATOS

BABA

BATL

BEEM

BEKE

BLDP

BLUE

BREA

CARA

CATX

CMAX

COCP

CSCO

CTRM

ESPR

FEIM

GLNG

GNLN

GOEV

GOLD

GRAB

HUYA

IPDN

JAGX

KNDI

LITE

MDAI

MIRA

MMAT

MNDY

NCPL

NMHI

NNDM

NUKK

OGEN

OUST

PSFE

QNRX

RDDT

RNAZ

RRAC

SACH

SAVA

SCYX

SOAR

STNE

TAYD

TCEHY

TCRT

TUSK

VUZI

WHLR

WKHS

WRNT

XXII

Screenshot 2024-10-02 at 5.44.40 PM

Biotech

General

Breakthrough Therapies And Novel Treatments - This Biopharma Is Out To Change The Game

Screenshot 2024-09-18 at 6.27.57 PM

MIRA Pharmaceuticals Advances Ketamir-2 Development Following Phase 1 Design Completion, Focusing On Early Clinical Efficacy Demonstration For Neuropathic Pain In 2025

Screenshot 2024-09-04 at 6.19.41 PM

TELO

Telomir Pharmaceuticals (NASDAQ: TELO) Featured In Local ABC Exclusive Showing Positive Outcomes Of Proposed Age Reversal Pill In Dogs

Screenshot 2024-08-26 at 4.53.37 PM

The Potential Of Ketamir-2: A Safer Treatment For Mental Health Disorders And Neuropathic Pain, IND Filing Expected By Year-End

Screenshot 2024-07-25 at 6.08.16 PM

MIRA Pharmaceuticals (NASDAQ: MIRA) Reports Promising Pre-Clinical Trial Results For Mental Health Treatment, To Submit Investigational New Drug Application By End Of Year

Press Releases

MIRA Pharmaceuticals Designates Neuropathic Pain as Primary Indication for Ketamir-2 and Submits Pre-IND Meeting Request to FDA

MIRA Pharmaceuticals Advances Ketamir-2 Development Following Phase 1 Design Completion, Focusing on Early Clinical Efficacy Demonstration for Neuropathic Pain in 2025

MIRA Pharmaceuticals Announces New Preclinical Data for Ketamir-2 to Be Presented at the 18th Annual Pain Therapeutics Summit in Boston on October 28-29, 2024

MIRA Pharmaceuticals Announces Ketamir-2 Outperforms Current FDA-Approved Neuropathic Pain Treatments, Gabapentin and Pregabalin, in Preclinical Study

MIRA Pharmaceuticals' Ketamir-2 Shows 60% Greater Efficacy Than FDA-Approved Gabapentin in Reversing Chemotherapy-Induced Neuropathic Pain

MIRA Reveals Innovative Phase I/IIa Protocol Design and Selection of Clinical Trial Site

MIRA Pharmaceuticals Validates Ketamir-2's Safety Profile With No Adverse Findings, Paving the Way for IND Submission by Year-End

MIRA Pharmaceuticals Submits IND for Ketamir-2 to FDA, Marking a Significant Milestone in the Company's Pipeline Development

Athira Pharma

Cara Therapeutics

Cognition Therapeutics, Inc. - Common Stock

Cognition Therapeutics

Comments

Mira Pharmaceuticals

Actualités

Dernières nouvelles pour Mira Pharmaceuticals (NASDAQ:MIRA) Stock

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL